We are live on
!
Find out more
BIOS
BioPlus Acquisition Corp. Class A Ordinary Shares
BIOS
BIOS
Delisted
BIOS was delisted on the 6th of October, 2023.
32 hedge funds and large institutions have $134M invested in BioPlus Acquisition Corp. Class A Ordinary Shares in 2023 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 12 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
25% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 12
42% less capital invested
Capital invested by funds: $231M → $134M (-$96.9M)
48% less funds holding
Funds holding: 61 → 32 (-29)
82% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 34
Holders
32
Holders Change
-29
Holders Change %
-47.54%
% of All Funds
0.5%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
6
Increased
9
Reduced
12
Closed
34
Calls
$107K
Puts
–
Net Calls
+$107K
Net Calls Change
+$3K
Top Buyers
| 1 |
MSU
Mizuho Securities USA
New York
|
+$10.7M |
| 2 |
QL
Quarry LP
New York
|
+$4.79M |
| 3 |
FTCM
First Trust Capital Management
Chicago,
Illinois
|
+$4.27M |
| 4 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$3.78M |
| 5 |
CC
Centiva Capital
New York
|
+$3.47M |
Top Sellers
| 1 |
CF
Cantor Fitzgerald
New York
|
-$13.2M |
| 2 |
PMAM
Picton Mahoney Asset Management
Toronto,
Ontario, Canada
|
-$12M |
| 3 |
AC
Aristeia Capital
Greenwich,
Connecticut
|
-$11.3M |
| 4 |
Calamos Advisors
Naperville,
Illinois
|
-$10.4M |
| 5 |
D.E. Shaw & Co
New York
|
-$9.33M |
